首页> 外文期刊>Cyclodextrin news >National Institutes of Health (NIH) has started evaluation of oral alpha-cyclodextrin for decreasing serum cholesterol
【24h】

National Institutes of Health (NIH) has started evaluation of oral alpha-cyclodextrin for decreasing serum cholesterol

机译:国立卫生研究院(NIH)已开始评估口服α-胞霉素,以减少血清胆固醇

获取原文
获取原文并翻译 | 示例
           

摘要

This single center, double-blinded, cross-over, placebo controlled clinical pilot study aimed at investigating the effectiveness of a soluble dietary fiber, alpha-cyclodextrin (alpha-CD), on blood lipid and lipoprotein levels in healthy human subjects. Alpha-CD is currently sold as an over the counter food supplement and is a common ingredient in many foods.
机译:这项单一中心,双盲,安慰剂控制的临床试验研究旨在研究可溶性饮食纤维,α-cyclodextrin(Alpha-CD)对健康人类受试者的血脂脂质和脂蛋白水平的有效性。 Alpha-CD目前是作为柜台食品补充剂出售的,在许多食品中都是常见的成分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号